Additionally, four novel targets were predicted (IGF2R, C5AR/C5AR1, RAB7, and SETD2) which are all involved in molecular pathways closely connected to prostate cancer, with some having been recently proposed as suitable targets for other types of cancers. Here, SETD2 is linked to cancer.